Promega Corporation

Miniaturizing Luminescent P450-Glo® Assays for HTS


  • Share
  • Print
  • Email
  • Download PDF


Determining toxicological properties of drug candidates is an important aspect of the drug discovery process. Using high-precision liquid handling instrumentation and robust, scalable reagent chemistries, toxicology assays can be brought closer to the high-throughput screening stages of drug development. We demonstrate the scalability of in vitro luminescent P450-Glo® Assays for high-throughput cytochrome P450 activity screening in low-volume 384- and 1536-well formats.

Cell Notes 10, 6–9.

1Tracy Worzella, 1Brad Larson, 1Jim Cali, 2Aoife Gallagher, and 3Eric Matthews

1Promega Corporation, 2Deerac Fluidics, 3BMG LABTECH

Publication Date: 2004

Download Article (148 KB)

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.

Spring adventures